Clinical Trial Update: Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating donor stem cell transplantation with sirolimus and treated immune cells, for blood and lymph cancers, terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome
• Myeloproliferative Disorders

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2018-12-31